Dawn E. Havrda

530 total citations
33 papers, 384 citations indexed

About

Dawn E. Havrda is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Dawn E. Havrda has authored 33 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Geriatrics and Gerontology and 7 papers in Economics and Econometrics. Recurrent topics in Dawn E. Havrda's work include Innovations in Medical Education (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Dawn E. Havrda is often cited by papers focused on Innovations in Medical Education (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Dawn E. Havrda collaborates with scholars based in United States. Dawn E. Havrda's co-authors include Arthur F. Harralson, Nicole Slater, Christina A. Spivey, Elizabeth A. Hall, Janet P. Engle, Sandra L. Kane‐Gill, Suman Rathbun, Seena L. Haines, Shaunta’ M. Ray and Dewey C. Scheid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Dawn E. Havrda

29 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn E. Havrda United States 12 90 78 64 62 50 33 384
Ashwin Kamath India 13 68 0.8× 64 0.8× 95 1.5× 59 1.0× 44 0.9× 65 600
Vincent Chan Australia 12 45 0.5× 108 1.4× 62 1.0× 72 1.2× 15 0.3× 34 382
Mary J. Ferrill United States 15 159 1.8× 70 0.9× 62 1.0× 85 1.4× 57 1.1× 26 667
Suzanne Novak United States 11 163 1.8× 72 0.9× 48 0.8× 37 0.6× 17 0.3× 17 415
Amy M. Franks United States 16 164 1.8× 51 0.7× 74 1.2× 81 1.3× 97 1.9× 48 659
Michael S. Monaghan United States 16 209 2.3× 147 1.9× 139 2.2× 133 2.1× 28 0.6× 53 670
João Felício Rodrigues Neto Brazil 10 35 0.4× 80 1.0× 19 0.3× 53 0.9× 25 0.5× 28 468
Heather P. Whitley United States 14 114 1.3× 60 0.8× 53 0.8× 79 1.3× 62 1.2× 40 554
Toni L. Ripley United States 11 106 1.2× 130 1.7× 79 1.2× 62 1.0× 121 2.4× 29 493
Marina Kawaguchi‐Suzuki United States 11 45 0.5× 44 0.6× 32 0.5× 25 0.4× 15 0.3× 24 292

Countries citing papers authored by Dawn E. Havrda

Since Specialization
Citations

This map shows the geographic impact of Dawn E. Havrda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Havrda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Havrda more than expected).

Fields of papers citing papers by Dawn E. Havrda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Havrda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Havrda. The network helps show where Dawn E. Havrda may publish in the future.

Co-authorship network of co-authors of Dawn E. Havrda

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Havrda. A scholar is included among the top collaborators of Dawn E. Havrda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Havrda. Dawn E. Havrda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crill, Catherine M., et al.. (2025). Faculty experiences developing and directing a novel multi-campus medication therapy management introductory pharmacy practice experience. Currents in Pharmacy Teaching and Learning. 17(7). 102362–102362.
2.
Hall, Elizabeth A., et al.. (2025). TikTok as a tool for learning top 300 drugs. American Journal of Pharmaceutical Education. 89(6). 101419–101419.
3.
Havrda, Dawn E., et al.. (2024). Best practices in online/distance pharmacy practice course didactic instruction. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(7). 670–676.
4.
Haines, Stuart T., Nicholas M. Fusco, Dawn E. Havrda, et al.. (2024). Educational outcomes necessary to enter pharmacy residency training: 2023 update. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(9). 952–956. 2 indexed citations
5.
Havrda, Dawn E., et al.. (2023). Evaluation of Academic and Nonacademic Factors of First-Generation Students Transitioning to a Pharmacy Program. American Journal of Pharmaceutical Education. 87(12). 100598–100598. 4 indexed citations
6.
Hall, Elizabeth A., et al.. (2023). Exploring the Relationship Between Imposter Phenomenon and Myers-Briggs Personality Types in Pharmacy Education. American Journal of Pharmaceutical Education. 87(6). 100076–100076. 4 indexed citations
7.
Havrda, Dawn E., et al.. (2022). Assessing Student Perceptions of Blended and Online Learning Courses in Pharmacoeconomics, Management, and Leadership. American Journal of Pharmaceutical Education. 87(4). ajpe9001–ajpe9001. 10 indexed citations
8.
Spivey, Christina A., et al.. (2021). Effects of peer-led study sessions on first-year student pharmacist performance in pharmacy math. Currents in Pharmacy Teaching and Learning. 13(9). 1168–1173. 2 indexed citations
9.
Hall, Elizabeth A., et al.. (2021). Effects of Remote Proctoring on Composite Examination Performance Among Doctor of Pharmacy Students. American Journal of Pharmaceutical Education. 85(8). 8410–8410. 18 indexed citations
10.
Havrda, Dawn E., et al.. (2021). Examining Preparatory Testing and Other Factors Associated With Performance on the Multistate Pharmacy Jurisprudence Examination. American Journal of Pharmaceutical Education. 86(7). 8774–8774. 3 indexed citations
11.
Spivey, Christina A., et al.. (2020). Longitudinal examination of perceived stress and academic performance of first-year student pharmacists. Currents in Pharmacy Teaching and Learning. 12(9). 1116–1122. 22 indexed citations
12.
Hohmeier, Kenneth C., Chasity M. Shelton, Dawn E. Havrda, & Justin Gatwood. (2020). The need to prioritize “prioritization” in clinical pharmacy service practice and implementation. Research in Social and Administrative Pharmacy. 16(12). 1785–1788. 10 indexed citations
13.
Havrda, Dawn E., et al.. (2011). Student Pharmacist, Pharmacy Resident, and Graduate Student Perceptions of Social Interactions With Faculty Members. American Journal of Pharmaceutical Education. 75(9). 180–180. 19 indexed citations
14.
Jones, Melissa C., et al.. (2011). Faculty Perceptions of Appropriate Faculty Behaviors in Social Interactions With Student Pharmacists. American Journal of Pharmaceutical Education. 75(4). 70–70. 13 indexed citations
15.
Havrda, Dawn E., et al.. (2011). Continuity of Care Between Family Practice Physicians and Hospitalist Services. Journal for Healthcare Quality. 35(1). 41–49. 10 indexed citations
16.
Havrda, Dawn E., et al.. (2009). Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals. Annals of Pharmacotherapy. 43(3). 469–477. 15 indexed citations
17.
Havrda, Dawn E., et al.. (2005). Enhanced Antithrombotic Effect of Warfarin Associated with Low‐Dose Alcohol Consumption. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(2). 303–307. 27 indexed citations
18.
Ripley, Toni L., Dawn E. Havrda, Steve M. Blevins, & Daniel J. Culkin. (2004). Early Evaluation of Hematuria in a Patient Receiving Anticoagulant Therapy and Detection of Malignancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(11). 1638–1640. 5 indexed citations
19.
Havrda, Dawn E., et al.. (2002). Possible Effect of Refrigeration of Warfarin on the International Normalized Ratio. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(1). 102–104.
20.
Havrda, Dawn E., Suman Rathbun, & Dewey C. Scheid. (2001). A Case Report of Warfarin Resistance Due to Azathioprine and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(3). 355–357. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashwin Kamath Breakdown of academic impact, for papers by Vincent Chan Breakdown of academic impact, for papers by Mary J. Ferrill Breakdown of academic impact, for papers by Suzanne Novak Breakdown of academic impact, for papers by Amy M. Franks Breakdown of academic impact, for papers by Michael S. Monaghan Breakdown of academic impact, for papers by João Felício Rodrigues Neto Breakdown of academic impact, for papers by Heather P. Whitley Breakdown of academic impact, for papers by Toni L. Ripley Breakdown of academic impact, for papers by Marina Kawaguchi‐Suzuki
Rankless by CCL
2026